Bazzato G, Coli U, Landini S, Lucatello S, Fracasso A, Righetto F, Scanferla F, Morachiello P
Int J Artif Organs. 1984 Mar;7(2):93-6.
Among 55 uremic patients who entered our CAPD program, 7 of them showed a reduction or loss of the ultrafiltration capacity (UF) of the peritoneal membrane (PM). They have been treated with high dose of Furosemide (F) to force residual urine output. Four appeared "responders" to drug administration with a significant increase in urine volume, Na excretion and, within a week period gained their dry body weight (BW). In the remaining 3 patients drug therapy resulted ineffective, and fluid removal was obtained by hemofiltration (HF). In both groups we noted an increase in the UF capacity of PM when their dry BW was obtained either by pharmacological or technical approach. These results support the assumption that the over-hydration status of the PM plays a major role in maintaining the UF process.
在进入我们持续性非卧床腹膜透析(CAPD)项目的55例尿毒症患者中,有7例腹膜(PM)超滤能力(UF)降低或丧失。他们接受了大剂量呋塞米(F)治疗以促使残余尿量增加。4例对药物治疗有“反应”,尿量、钠排泄量显著增加,且在一周内体重恢复到干体重(BW)。其余3例患者药物治疗无效,通过血液滤过(HF)清除液体。在两组中,当通过药物或技术方法达到干体重时,我们都注意到PM的超滤能力有所增加。这些结果支持以下假设,即PM的过度水化状态在维持超滤过程中起主要作用。